Home/Filings/4/0000914190-19-000507
4//SEC Filing

Spandow Oliver J. 4

Accession 0000914190-19-000507

CIK 0001196298other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:13 PM ET

Size

10.3 KB

Accession

0000914190-19-000507

Insider Transaction Report

Form 4
Period: 2019-12-16
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-12-16+5,5685,568 total
    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
  • Award

    Common Stock

    2019-12-16+3,44814,234 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $5.58Exp: 2028-08-10Common Stock (9,466 underlying)
    9,466
  • Stock Option (Right to Buy)

    Exercise: $5.85Exp: 2028-12-19Common Stock (5,161 underlying)
    5,161
Footnotes (4)
  • [F1]On December 16, 2019, the Company granted 3,448 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Spandow in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]The option vests as to 3,156 shares on 8/10/19 and as to 3,155 shares on each of 8/10/20 and 8/10/21.
  • [F3]The option vests as to 1,721 shares on 12/19/18 and as to 1,720 shares on each of 12/19/19 and 12/19/20.
  • [F4]On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Mr. Spandow as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001749836

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:13 PM ET
Size
10.3 KB